Recommended Resource:
MM&M's Pipeline 2008
Medical Marketing & Media, December 2007

What are the promising drugs of 2008? Medical Marketing & Media’s “Pipeline 2008” looks at pharmaceutical products under development and highlights 17 that are generating the most buzz in major categories such as cardiovascular, diabetes, central nervous system, oncology and respiratory. Six GfK U.S. Healthcare Companies marketing researchers are featured in the piece providing their expert opinions on both the therapeutic classes and specific drugs covered.

To download the article Pipeline 2008, click here.





For more insights on these therapeutic areas from the experts included
in the article, please contact the appropriate GfK U.S. Healthcare Companies consultant listed below:

Bill Bowman, J.D.
Vice President & Category Business Leader, Oncology
GfK Market Measures
bbowman@gfkmm.com

Dave Jacobson, Ph.D.
Senior Vice President of the Roper Global Diabetes Program
GfK Market Measures
djacobson@gfkmm.com

Kim Lazarus, M.B.A.
Vice President & Category Business Leader, Neurology
GfK Market Measures
klazarus@gfkmm.com

Geoff Penney
Vice President & Category Business Leader, Psychiatry
GfK Market Measures
gpenney@gfkmm.com

Noah Pines
Executive Vice President & Viral Diseases Expert
GfK V2
npines@gfkv2.com

Sue Ramspacher, M.A.
Senior Vice President & Category Business Leader, Respiratory & Women’s Health
GfK Market Measures
sramspacher@gfkmm.com